--- title: "Dow 30 Earnings: DowDuPont Fourth Quarter 2018" description: dow 30, DowDuPont, fourth-quarter, sales of about $20.1 billion roughly matched the prior-year figure, as price and volume gains were offset by unfavorable currency movements. Earnings per share came in at $0.77, slightly ahead of the year-ago figure of $0.74. image: https://investor.valueline.com/hubfs/social-suggested-images/iStock-184958661-4.jpg --- [![The Value Line Blog](https://investor.valueline.com/hubfs/VL%20Blog%20Images/vl_blog_header.png)](https://investor.valueline.com/blog) [Stock Highlights](https://investor.valueline.com/blog/topic/stock-highlights) # Dow 30 Earnings: DowDuPont Fourth Quarter 2018 January 31, 2019 Diversified-chemicals manufacturer and Dow-30 component **DowDuPont** ([DWDP ](https://research.valueline.com/research?&_ga=2.119068545.943416033.1548946811-727488664.1548946811#sec=company&sym=DWDP)– [Free DowDuPont Stock Report](https://research.valueline.com/api/report?documentID=2185-VL_20190104_VLIS_DWDP_25784_01-74GPRROU0384Q1R3GGSQREV3D9&symbol=DWDP)) has reported fourth-quarter earnings. Sales of about $20.1 billion roughly matched the prior-year figure, as price and volume gains were offset by unfavorable currency movements. Earnings per share came in at $0.77, slightly ahead of the year-ago figure of $0.74. Efforts by the company to reduce costs have supported profitability. The Agriculture division benefited from sales of new crop protection products and the timing of seed shipments in the Americas, though this was partly offset by currency pressures. The top line declined slightly at the Performance Materials & Coatings business, as sales gains in most areas were erased by a decline in the Asia/Pacific region. The Industrial Intermediates & Infrastructure line reported moderate sales growth, thanks to strength in Asian and North American markets. Meanwhile, the Packaging & Specialty Plastics operation benefited from demand in Asian and Latin American markets as well as new capacity from the Sadara joint venture and the U.S. Gulf Coast. However, this was nullified by weakness in North America, and total sales fell roughly 4% here. Elsewhere, the Electronics & Imaging business benefited from robust demand in chemical mechanical planarization and advanced packaging end-markets as well as healthy gains in display technologies. But, ongoing softness in the photovoltaics market and lower interconnect solutions volumes impacted performance here. In addition, the Nutrition & Biosciences unit experienced healthy growth in probiotics and strong performance in systems & texturants. Results were particularly healthy in the Asia/Pacific region. Finally, the Safety & Construction business was helped by continued strength across industrial, oil & gas, aerospace, and life & personal protection end-markets. This resulted in strong volume advances in Nomex fibers and Kevlar high-strength materials, which more than offset softness in domestic residential construction demand. The company expects that global economic expansion will continue in the current year, though at a somewhat slower pace. We have lowered our estimates slightly for full-year 2019, and now anticipate sales and earnings per share of $92 billion and $4.30, respectively. The separation of DowDuPont into three standalone entities remains on track. The split of the Materials Science division is scheduled for April 1st. This operation will be called Dow. Corteva Agriscience is expected to be separated from the new DuPont on June 1st. DuPont will house the Specialty Products division. The senior leadership teams for the three businesses have been announced, as well as the boards of directors. Investors were not happy with the latest results, and sent the stock trading lower on today's news.    - Michael Napoli *At the time of this article’s writing, the author did not have positions in any of the companies mentioned.* [![Register now for our free One Stock to Buy webinar](https://no-cache.hubspot.com/cta/default/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5.png)](https://cta-redirect.hubspot.com/cta/redirect/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5) ### Popular Posts Search Search Blog ### Topics - [Investing 101 (2)](https://investor.valueline.com/blog/topic/investing-101) - [Market Commentary (37)](https://investor.valueline.com/blog/topic/market-commentary) - [Stock Highlights (390)](https://investor.valueline.com/blog/topic/stock-highlights) - [Stock Market Today (2071)](https://investor.valueline.com/blog/topic/stock-market-today) Copyright 2026 Value Line, Inc. All Rights Reserved. Factual material is obtained from sources believed to be reliable and is provided without warranties of any kind. VALUE LINE IS NOT RESPONSIBLE FOR ANY ERRORS OR OMISSIONS HEREIN OR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. This blog is strictly for subscriber's own, non-commercial, internal use. No part of it may be reproduced, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product. Officers, directors, or employees of Value Line, Inc. and its affiliates and subsidiaries, and EULAV Asset Management, may own stocks that are featured in this email. Nothing herein should be construed as an offer to buy or sell securities or to give individual investment advice. Value Line, the Value Line logo, The Most Trusted Name in Investment Research, “Smart research. Smarter investing.”, The Value Line Investment Survey, Timeliness, and Safety are trademarks or registered trademarks of Value Line, Inc. and/or its affiliates in the United States and other countries.